Mytesi Tablet, Coated
Product Images NDC 70564-802

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mytesi (NDC 70564-802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Napo Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Following Chemical Structure For Mytesi (crofelemer) Is Delayed-release Tablets Is An Anti-diarrheal, Enteric-coated Drug Product For Oral Administration. It Contains 125 mg Of Crofelemer, A Botanical Drug Substance That Is Derived From The Red Latex Of Croton Lechleri Müll. Arg. Crofelemer Is An Oligomeric Proanthocyanidin Mixture Primarily Composed Of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, And (–)–epigallocatechin Monomer Units Linked In Random Sequence, As Represented Below. The Average Degree Of Polymerization For The Oligomers Ranges Between 5 And 7.5, As Determined By Phloroglucinol Degradation. (Mytesi 01)

The Following Chemical Structure For Mytesi (crofelemer) Is Delayed-release Tablets Is An Anti-diarrheal, Enteric-coated Drug Product For Oral Administration. It Contains 125 mg Of Crofelemer, A Botanical Drug Substance That Is Derived From The Red Latex Of Croton Lechleri Müll. Arg. Crofelemer Is An Oligomeric Proanthocyanidin Mixture Primarily Composed Of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, And (–)–epigallocatechin Monomer Units Linked In Random Sequence, As Represented Below. The Average Degree Of Polymerization For The Oligomers Ranges Between 5 And 7.5, As Determined By Phloroglucinol Degradation. (Mytesi 01)
FDA Label Image

Principal Display Panelndc 70564-802-60 Mytesi (crofelemer) Delayed-release Tablets 125 mg Swallow Tablet Whole. Do Not Crush Or Chew. 60 Enteric Coated Tablets Rx Only (Mytesi 03)

Principal Display Panelndc 70564-802-60 Mytesi (crofelemer) Delayed-release Tablets 125 mg Swallow Tablet Whole. Do Not Crush Or Chew. 60 Enteric Coated Tablets Rx Only (Mytesi 03)
Each tablet contains 125 mg of an oral (crofelemer) antidiarrheal drug, sold under the name "Storeal." The tablets should be stored between 20°C to 25°C (68°F to 77°F). The recommended dosage is one tablet per day. The drug is manufactured by Petesi, and the NDC number is 70564-802-60. The tablet must be swallowed whole and should not be chewed or crushed. Further dosage and administration information is unavailable.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.